Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
135M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
18.4K
-
Shares change
-
+403
-
Total reported value, excl. options
-
$183K
-
Value change
-
+$3.99K
-
Number of buys
-
1
-
Price
-
$9.90
Significant Holders of Tango Therapeutics, Inc. - Common Stock (TNGX) as of Q4 2023
1 filings reported holding TNGX - Tango Therapeutics, Inc. - Common Stock as of Q4 2023.
Tango Therapeutics, Inc. - Common Stock (TNGX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4K shares
of 135M outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include TRV GP IV, LLC (19.4M shares), EcoR1 Capital, LLC (13.3M shares), FMR LLC (9.79M shares), Boxer Capital, LLC (8.2M shares), Nextech Invest Ltd. (5.53M shares), Southpoint Capital Advisors LP (5.28M shares), BlackRock Inc. (3.95M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.4M shares), VANGUARD GROUP INC (2.98M shares), and Bain Capital Life Sciences Investors, LLC (2.89M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.